Annual FCF
-$44.90 M
-$4.25 M-10.46%
December 1, 2024
Summary
- As of March 12, 2025, CMPX annual free cash flow is -$44.90 million, with the most recent change of -$4.25 million (-10.46%) on December 1, 2024.
- During the last 3 years, CMPX annual FCF has fallen by -$23.66 million (-111.45%).
- CMPX annual FCF is now -111.45% below its all-time high of -$21.23 million, reached on December 31, 2021.
Performance
CMPX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$9.16 M
+$1.93 M+17.42%
December 1, 2024
Summary
- As of March 12, 2025, CMPX quarterly free cash flow is -$9.16 million, with the most recent change of +$1.93 million (+17.42%) on December 1, 2024.
- Over the past year, CMPX quarterly FCF has increased by +$4.73 million (+34.03%).
- CMPX quarterly FCF is now -139.59% below its all-time high of -$3.82 million, reached on September 1, 2021.
Performance
CMPX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$44.90 M
+$3.20 M+6.65%
December 1, 2024
Summary
- As of March 12, 2025, CMPX TTM free cash flow is -$44.90 million, with the most recent change of +$3.20 million (+6.65%) on December 1, 2024.
- Over the past year, CMPX TTM FCF has dropped by -$2.59 million (-6.13%).
- CMPX TTM FCF is now -477.63% below its all-time high of -$7.77 million, reached on March 1, 2020.
Performance
CMPX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
CMPX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -10.5% | +34.0% | -6.1% |
| 3 y3 years | -111.5% | +34.0% | -6.1% |
| 5 y5 years | -39.4% | +34.0% | -6.1% |
CMPX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -111.5% | at low | -101.9% | +34.0% | -104.7% | +6.7% |
| 5 y | 5-year | -111.5% | at low | -139.6% | +34.0% | -477.6% | +6.7% |
| alltime | all time | -111.5% | at low | -139.6% | +34.0% | -477.6% | +6.7% |
Compass Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$44.90 M(+10.5%) | -$9.16 M(-17.4%) | -$44.90 M(-6.7%) |
| Sep 2024 | - | -$11.10 M(+3.2%) | -$48.10 M(+12.0%) |
| Jun 2024 | - | -$10.75 M(-22.6%) | -$42.94 M(+1.5%) |
| Mar 2024 | - | -$13.89 M(+12.3%) | -$42.31 M(+4.1%) |
| Dec 2023 | -$40.65 M(+18.4%) | -$12.36 M(+108.4%) | -$40.65 M(+4.3%) |
| Sep 2023 | - | -$5.93 M(-41.4%) | -$38.98 M(-11.4%) |
| Jun 2023 | - | -$10.12 M(-17.2%) | -$44.02 M(+14.5%) |
| Mar 2023 | - | -$12.23 M(+14.3%) | -$38.43 M(+11.9%) |
| Dec 2022 | -$34.34 M | -$10.70 M(-2.5%) | -$34.34 M(+18.1%) |
| Sep 2022 | - | -$10.97 M(+141.8%) | -$29.08 M(+32.6%) |
| Jun 2022 | - | -$4.54 M(-44.2%) | -$21.94 M(-7.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$8.14 M(+49.5%) | -$23.64 M(+11.3%) |
| Dec 2021 | -$21.23 M(-21.1%) | - | - |
| Dec 2021 | - | -$5.44 M(+42.3%) | -$21.23 M(-5.4%) |
| Sep 2021 | - | -$3.82 M(-38.7%) | -$22.45 M(-13.0%) |
| Jun 2021 | - | -$6.24 M(+8.8%) | -$25.80 M(+3.7%) |
| Mar 2021 | - | -$5.73 M(-13.9%) | -$24.87 M(-7.6%) |
| Dec 2020 | -$26.91 M(-16.4%) | -$6.66 M(-7.2%) | -$26.91 M(+32.9%) |
| Sep 2020 | - | -$7.18 M(+35.3%) | -$20.25 M(+54.9%) |
| Jun 2020 | - | -$5.30 M(-31.8%) | -$13.08 M(+68.2%) |
| Mar 2020 | - | -$7.77 M | -$7.77 M |
| Dec 2019 | -$32.21 M(-9.8%) | - | - |
| Dec 2018 | -$35.70 M | - | - |
FAQ
- What is Compass Therapeutics annual free cash flow?
- What is the all time high annual FCF for Compass Therapeutics?
- What is Compass Therapeutics annual FCF year-on-year change?
- What is Compass Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Compass Therapeutics?
- What is Compass Therapeutics quarterly FCF year-on-year change?
- What is Compass Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Compass Therapeutics?
- What is Compass Therapeutics TTM FCF year-on-year change?
What is Compass Therapeutics annual free cash flow?
The current annual FCF of CMPX is -$44.90 M
What is the all time high annual FCF for Compass Therapeutics?
Compass Therapeutics all-time high annual free cash flow is -$21.23 M
What is Compass Therapeutics annual FCF year-on-year change?
Over the past year, CMPX annual free cash flow has changed by -$4.25 M (-10.46%)
What is Compass Therapeutics quarterly free cash flow?
The current quarterly FCF of CMPX is -$9.16 M
What is the all time high quarterly FCF for Compass Therapeutics?
Compass Therapeutics all-time high quarterly free cash flow is -$3.82 M
What is Compass Therapeutics quarterly FCF year-on-year change?
Over the past year, CMPX quarterly free cash flow has changed by +$4.73 M (+34.03%)
What is Compass Therapeutics TTM free cash flow?
The current TTM FCF of CMPX is -$44.90 M
What is the all time high TTM FCF for Compass Therapeutics?
Compass Therapeutics all-time high TTM free cash flow is -$7.77 M
What is Compass Therapeutics TTM FCF year-on-year change?
Over the past year, CMPX TTM free cash flow has changed by -$2.59 M (-6.13%)